Aratana Therapeutics Inc (PETX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

11400 TOMAHAWK CREEK PARKWAY, SUITE 340 LEAWOOD, KS 66211

PetIQ, Inc. manufactures and distributes health and wellness products for dogs and cats. The Company offers pet prescription medications, over-the-counter flea and tick preventives, health and wellness supplements, and dog and cat treats. PetIQ operates in the United States.

Data as of 2019-09-05 03:30:51 -0400
Market Cap241.095 Million Shares Outstanding49.003 Million Avg 30-day Volume
P/E Ratio Dividend Yield EPS-0.268
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA 52-week High/Low7.16 / 3.3 Next Earnings Date Price to Cash FLow (P/CF)
Data provided by IEX Cloud
View SEC Filings from PETX instead.

View recent insider trading info

Funds Holding PETX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PETX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

RAINES MERILEE

  • Director
No longer subject to file 2019-07-18 0

HOCKADAY IRVINE O JR

  • Director
No longer subject to file 2019-07-18 0

YARNO WENDY L

  • Director
No longer subject to file 2019-07-18 0

TOOMAN CRAIG A PRESIDENT AND CEO

  • Officer
  • Director
No longer subject to file 2019-07-18 0

ROCHE ROBERT P JR

  • Director
No longer subject to file 2019-07-18 0

ROBINSON LOWELL W

  • Director
No longer subject to file 2019-07-18 0

BRINKLEY DAVID L

  • Director
No longer subject to file 2019-07-18 0

VANDER VORT JOHN

  • Director
No longer subject to file 2019-07-18 0

BARBAROSH CRAIG A.

  • Director
No longer subject to file 2019-07-18 0

BROADFIN HEALTHCARE MASTER FUND LTD

BROADFIN CAPITAL, LLC

KOTLER KEVIN

  • 10% Owner
No longer subject to file 2019-07-18 0

HEINEN ERNST CHIEF DEVELOPMENT OFFICER

  • Officer
No longer subject to file 2019-07-18 0

READY CHRISTOPHER T VP OF SALES AND MARKETING

  • Officer
No longer subject to file 2019-07-18 0

AYRES JOHN C SEE REMARKS

  • Officer
No longer subject to file 2019-07-18 0

HELLUMS RHONDA LYNETTE CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2019-07-18 0

ST PETER STEVEN PRESIDENT AND CEO

  • Officer
  • Director
603,623 2018-12-17 0

BREGE LAURA

  • Director
13,500 2018-07-27 0

STANDRIDGE BRENT CHIEF OPERATING OFFICER

  • Officer
99,967 2018-06-25 0

GERBER ROBERT BENTHALL JR

  • Director
24,042 2017-06-21 0

STEPHANUS JULIA A CHIEF COMMERCIAL OFFICER

  • Officer
127,503 2016-06-28 0

LICHTER JAY

  • Director
2,374,568 2015-07-15 0

RHODES LINDA CHIEF SCIENTIFIC OFFICER

  • Officer
423,205 2015-04-24 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments